Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Tetra Bio Pharma Inc (TBP.TO)

Tetra Bio Pharma Inc (TBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Tetra Bio-Pharma Announces Listing to OTCPink Market PR Newswire - Fri Feb 10, 2023

/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTC-PINK: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

TBP.TO : 0.0250 (unch)
TBPMF : 0.0002 (-77.78%)
Tetra Bio-Pharma Announces Listing to OTCPink Market Newswire.ca - Fri Feb 10, 2023

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTC-PINK: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

TBPMF : 0.0002 (-77.78%)
TBP.TO : 0.0250 (unch)
REDUVO™ Marketing Approval on the Right Path PR Newswire - Thu Dec 22, 2022

/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) a leader in cannabinoid-derived drug discovery and...

TBP.TO : 0.0250 (unch)
TBPMF : 0.0002 (-77.78%)
REDUVO™ Marketing Approval on the Right Path Newswire.ca - Thu Dec 22, 2022

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) a leader in cannabinoid-derived drug discovery and development...

TBPMF : 0.0002 (-77.78%)
TBP.TO : 0.0250 (unch)
Stocks in play: Tetra Bio-Pharma Inc. Baystreet - Tue Dec 6, 2022

Announced today significant results from the study of Onternabez combined with Favipiravir against ARDS ...

TBP.TO : 0.0250 (unch)
Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir Newswire.ca - Tue Dec 6, 2022

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development...

TBPMF : 0.0002 (-77.78%)
TBP.TO : 0.0250 (unch)
Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir PR Newswire - Tue Dec 6, 2022

/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

TBP.TO : 0.0250 (unch)
TBPMF : 0.0002 (-77.78%)
Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003 PR Newswire - Tue Nov 29, 2022

/PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and...

TBP.TO : 0.0250 (unch)
TBPMF : 0.0002 (-77.78%)
Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003 Newswire.ca - Tue Nov 29, 2022

/CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development...

TBPMF : 0.0002 (-77.78%)
TBP.TO : 0.0250 (unch)
Most actively traded companies on the Toronto Stock Exchange Canadian Press - Thu Nov 24, 2022

TORONTO — Some of the most active companies traded Thursday on the Toronto Stock Exchange:

MFC.TO : 45.38 (+0.60%)
ENB.TO : 58.77 (-1.29%)
XLY.TO : 0.0400 (unch)
SU.TO : 53.16 (-1.68%)
TBP.TO : 0.0250 (unch)
BNS.TO : 75.25 (-0.03%)

Barchart Exclusives

1 Dividend Aristocrat to Bet on Trump's Tariffs and the Fed's Rate Cuts Barchart - 25 minutes ago
Nucor is one stock that stands to benefit from the Fed's rate cuts as well as any possible tariffs under a Trump administration. It is also a dividend aristocrat, and has increased its payouts for over 5 decades. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot